Congenital syphilis primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 6: | Line 6: | ||
*Safer sexual practices may help prevent syphilis. If you suspect you have a [[sexually transmitted disease (patient information)|sexually transmitted disease]] such as [[Syphilis (patient information)|syphilis]], seek medical attention immediately to avoid complications like infecting your baby during pregnancy or birth. | *Safer sexual practices may help prevent syphilis. If you suspect you have a [[sexually transmitted disease (patient information)|sexually transmitted disease]] such as [[Syphilis (patient information)|syphilis]], seek medical attention immediately to avoid complications like infecting your baby during pregnancy or birth. | ||
===Prenatal care=== | |||
* Obtaining maternal blood for serologic testing at the first visit unless the results of a previous test during the current pregnancy are available. A second STS should be performed at the beginning of the third trimester (28 weeks). | |||
* Providing each patient with a card identifying what test was performed, the date it was done, the result, what treatment (if any) was given, and the clinic's name and telephone number. | |||
* Maintaining a list, arranged by date of test and patient's name, of the results of the STS. Entries should be maintained for 1 year after the pregnancy is terminated. Prenatal care providers are responsible for determining the serologic status of their patients. Providers either should obtain the specimen or should document that a nonreactive test was obtained earlier in the pregnancy. The patient-borne record of STS and reactive results will assist in this documentation. | |||
* Identifying specimens from pregnant women by clearly labeling the laboratory slips prenatal. Reactive tests should be followed by the STD program as part of an ongoing surveillance activity (see section 2). | |||
* Flagging the charts of clients whose serologic tests are reactive. Charts should remain flagged until the patient returns to the clinic. If the patient does not return or respond to routine notification, the local health department should be informed and referral services requested. | |||
* Instructing pregnant patients who may not be involved in mutually monogamous relationships to insist that their sex partners use condoms during the full term of the pregnancy. | |||
* Providing monthly quantitative nontreponemal serologic tests for the remainder of the current pregnancy of women who have been treated for early syphilis. Women who show a fourfold rise in titer should be retreated. Treated women who do NOT show a fourfold decrease in titer within 3 months should be retreated. After delivery, follow-up should be conducted as outlined for nonpregnant patients. | |||
* Testing all patients for syphilis (RPR or VDRL) 1 month after they have completed treatment for any other STD diagnosed during pregnancy. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 14:45, 21 December 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
|
Congenital syphilis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Congenital syphilis primary prevention On the Web |
|
American Roentgen Ray Society Images of Congenital syphilis primary prevention |
|
Risk calculators and risk factors for Congenital syphilis primary prevention |
Primary Prevention
- Safer sexual practices may help prevent syphilis. If you suspect you have a sexually transmitted disease such as syphilis, seek medical attention immediately to avoid complications like infecting your baby during pregnancy or birth.
Prenatal care
- Obtaining maternal blood for serologic testing at the first visit unless the results of a previous test during the current pregnancy are available. A second STS should be performed at the beginning of the third trimester (28 weeks).
- Providing each patient with a card identifying what test was performed, the date it was done, the result, what treatment (if any) was given, and the clinic's name and telephone number.
- Maintaining a list, arranged by date of test and patient's name, of the results of the STS. Entries should be maintained for 1 year after the pregnancy is terminated. Prenatal care providers are responsible for determining the serologic status of their patients. Providers either should obtain the specimen or should document that a nonreactive test was obtained earlier in the pregnancy. The patient-borne record of STS and reactive results will assist in this documentation.
- Identifying specimens from pregnant women by clearly labeling the laboratory slips prenatal. Reactive tests should be followed by the STD program as part of an ongoing surveillance activity (see section 2).
- Flagging the charts of clients whose serologic tests are reactive. Charts should remain flagged until the patient returns to the clinic. If the patient does not return or respond to routine notification, the local health department should be informed and referral services requested.
- Instructing pregnant patients who may not be involved in mutually monogamous relationships to insist that their sex partners use condoms during the full term of the pregnancy.
- Providing monthly quantitative nontreponemal serologic tests for the remainder of the current pregnancy of women who have been treated for early syphilis. Women who show a fourfold rise in titer should be retreated. Treated women who do NOT show a fourfold decrease in titer within 3 months should be retreated. After delivery, follow-up should be conducted as outlined for nonpregnant patients.
- Testing all patients for syphilis (RPR or VDRL) 1 month after they have completed treatment for any other STD diagnosed during pregnancy.